Bone Growth Stimulator Market Potential Growth by Leading Players Orthofix International N.V., Aetna Inc., DJO LLC, Smith & Nephew, Zimmer Biomet Holdings Inc., Ossatec Benelux BV, Elizur, Bioventus LLC

According to the International Osteoporosis Foundation, osteoporosis causes around 8.9 million fractures per year that is around one osteoporotic fracture every 3 seconds. Moreover, osteoporosis is expected to affect around 200 million women worldwide. Around 80%, 75%, 70% and 58% of forearm, humerus, hip and spine fractures, respectively, affects women. A fracture, especially in the spinal cord requires bone surgery. Out of these surgeries, a significant number of patients will need bone growth stimulators due to steady recovery. This in turn will drive the growth of the overall bone growth stimulator market during the forecast period.

Download PDF Brochure @ www.coherentmarketinsights.com/insight/request-pdf/225

A bone growth stimulator sends low intensity electrical signals to the site of fusion. These electrical signals trigger natural bone healing process of the body, which are sometimes impaired in surgery patients. The global demographic scenario is quite diverse. For instance, India is a country with more than half of the population in the youth bracket, whereas China and the U.S. have the maximum geriatric population. Bone growth stimulators have observed an implausible demand in the past few years. The early development of BGS began in the U.S. and the innovation in technology has made developed and sophisticated products to enter the market.

Some of the factors such as rise in per capita healthcare spending, increase in personal income, and improvement in healthcare sector will boost growth of the market in bone growth stimulator, globally. Nonetheless, a variety of factors such as uncertainty about efficacy, and availability of alternative therapies may hinder the growth of the overall market.

According to the International Osteoporosis Foundation, the number of vertebral fractures that are not recognized is as high 45% in North America, and 46% in Latin America. After a surgery for a vertebral fracture, there is a high risk of requiring hospitalization for another fracture in the following years. To decrease the morbidity rates in patients with a history of bone surgeries, bone growth stimulators are used extensively. As the number of cases is increasing at an alarming rate, so is the need for bone growth stimulators. This will encourage the growth of the global bone growth stimulator market in the forecast period.

Some of the companies operating in the bone growth stimulator market in the current scenario are Orthofix International N.V., Aetna Inc., DJO LLC, Smith & Nephew, Zimmer Biomet Holdings Inc., Ossatec Benelux BV, Elizur, Bioventus LLC., Orchid Medical, IGEA S.p.A, and Verve Consulting Inc.

Request a Sample Copy @ www.coherentmarketinsights.com/insight/request-sample/225

Bone growth stimulator market Taxonomy

On the basis of type of product, the global bone growth stimulator market is classified into:

Pulsed Electromagnetic Field (PEMF) Devices
Capacitive Coupling (CC) Devices
Combined Magnetic Field (CMF) Devices
Ultrasound Bone Growth Stimulators Surgical Devices
Invasive Electrical Bone Growth Stimulators
On the basis of type of application, the global market is classified into:

Trauma injury and Fractures
Spinal Fusion
Osteogenesis

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

1001 4th Ave,, #3200, Seattle, WA 98154

This release was published on openPR.